VIV(VIV)
VIV
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $63.87B | $67.55B | $70.91B | $79.47B | $66.15B |
| Low | $62.79B | $64.80B | $68.92B | $77.24B | $64.29B |
| High | $65.05B | $69.89B | $72.12B | $80.82B | $67.27B |
| EBITDA Avg | $27.04B | $28.60B | $30.02B | $33.64B | $28.00B |
| Low | $26.58B | $27.43B | $29.18B | $32.70B | $27.22B |
| High | $27.54B | $29.59B | $30.53B | $34.22B | $28.48B |
| EBIT Avg | $12.68B | $13.42B | $14.08B | $15.78B | $13.14B |
| Low | $12.47B | $12.87B | $13.69B | $15.34B | $12.77B |
| High | $12.92B | $13.88B | $14.32B | $16.05B | $13.36B |
| Net Income Avg | $7.94B | $10.18B | $11.63B | $18.03B | — |
| Low | $7.11B | $9.58B | $11.20B | $17.38B | — |
| High | $9.01B | $10.44B | $11.88B | $18.43B | — |
| EPS Avg | $4.92 | $6.32 | $7.21 | $11.19 | — |
| Low | $4.41 | $5.95 | $6.95 | $10.78 | — |
| High | $5.59 | $6.48 | $7.37 | $11.44 | — |
| Analysts (Rev / EPS) | 9 / 3 | 9 / 4 | 3 / 2 | 4 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $15.92B | $16.56B | $16.53B | $16.86B | $17.20B | $17.75B | $17.67B | $17.97B |
| Low | $15.83B | $16.51B | $16.43B | $16.76B | $17.10B | $17.64B | $17.56B | $17.86B |
| High | $15.97B | $16.61B | $16.69B | $17.03B | $17.37B | $17.93B | $17.85B | $18.15B |
| EBITDA Avg | $6.74B | $7.01B | $7.00B | $7.14B | $7.28B | $7.52B | $7.48B | $7.61B |
| Low | $6.70B | $6.99B | $6.95B | $7.10B | $7.24B | $7.47B | $7.44B | $7.56B |
| High | $6.76B | $7.03B | $7.07B | $7.21B | $7.35B | $7.59B | $7.56B | $7.68B |
| EBIT Avg | $3.16B | $3.29B | $3.28B | $3.35B | $3.42B | $3.53B | $3.51B | $3.57B |
| Low | $3.14B | $3.28B | $3.26B | $3.33B | $3.40B | $3.50B | $3.49B | $3.55B |
| High | $3.17B | $3.30B | $3.32B | $3.38B | $3.45B | $3.56B | $3.54B | $3.60B |
| Net Income Avg | $2.09B | $2.50B | $2.03B | $2.33B | $2.66B | $2.63B | $2.42B | $2.69B |
| Low | $1.84B | $2.41B | $2.01B | $2.31B | $2.64B | $2.61B | $2.40B | $2.67B |
| High | $2.26B | $2.53B | $2.05B | $2.36B | $2.69B | $2.67B | $2.45B | $2.73B |
| EPS Avg | $1.30 | $1.56 | $1.26 | $1.45 | $1.66 | $1.64 | $1.51 | $1.68 |
| Low | $1.15 | $1.50 | $1.25 | $1.44 | $1.64 | $1.63 | $1.49 | $1.66 |
| High | $1.41 | $1.58 | $1.28 | $1.47 | $1.68 | $1.66 | $1.53 | $1.70 |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |